CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 19,565 shares at $15.14 ($296,269)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Gift Director gave 709 shares (gift)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 8-K Event Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 70,000 shares at an average $15.15 ($1,060,701)
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 16 of 44 · 872 filings